Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/2003
06/18/2003CN1111357C Food products having enhanced cocoa polyphenol content and processes for producing same
06/17/2003US6579989 Sulphostin analogue and process for producing sulphostin and its analogue
06/17/2003US6579982 Treating inflammation, cancer
06/17/2003US6579970 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes.
06/17/2003US6579969 Purified polypeptide of given amino acid sequence; serine/threonine kinase
06/17/2003US6579900 Can be used to reduce pain, reducing nausea in an individual undergoing chemotherapy, suppressing appetite, reducing intraocular pressure, and suppressing the immune system in an individual with an organ transplant.
06/17/2003US6579896 Method for treating allergies using substituted pyrazoles
06/17/2003US6579883 Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors
06/17/2003US6579877 Combination of benzoquinazoline antifolates and protecting agents
06/17/2003US6579874 Substituted azoles
06/17/2003US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines
06/17/2003US6579870 5-(1,4-diazepan-1-yl)-2-((3 -fluorophenyl)sulfonyl)phenylamine for example; treatment of diseases or disorders of the central nervous system; modulation of serotonin (5-HT) activity
06/17/2003US6579864 Arthritic diseases and/or autoimmune diseases
06/17/2003US6579861 Administering alpha -hydroxy-2-methylene-19-nor-homopregnacalciferol for therapy of psoriasis
06/17/2003US6579853 For inhibiting apoptosis or apoptosis-like cell death
06/17/2003US6579526 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
06/17/2003US6579521 Methods of therapy for HIV infection
06/17/2003CA2232410C Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
06/17/2003CA2123315C Therapeutic agents which are antagonists or partial agonists of human interleukin 4
06/13/2003WO2003047602A1 Immunostimulatory oligodeoxynucleotides
06/13/2003CA2452909A1 Immunostimulatory oligodeoxynucleotides
06/12/2003WO2003048781A1 Uses of the glycine-n-acyl transferase (gnat) for the diagnosis and therapy of inflammatory diseases and sepsis
06/12/2003WO2003048780A2 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis
06/12/2003WO2003048772A2 Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
06/12/2003WO2003048390A1 A process for the preparation of a non-toxic anthrax vaccine
06/12/2003WO2003048383A2 Effectors of innate immunity
06/12/2003WO2003048375A1 Hybrid glycosylated products and their production and use
06/12/2003WO2003048334A2 Immunocytokines with modulated selectivity
06/12/2003WO2003048327A2 Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection
06/12/2003WO2003048209A1 Bispecific anti-cd19 x anti-cd16 antibodies and uses thereof
06/12/2003WO2003048206A2 Growth hormone agonist peptides and their uses
06/12/2003WO2003048205A2 Novel proteins with il-6 inhibiting activity
06/12/2003WO2003048193A2 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN
06/12/2003WO2003048180A1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
06/12/2003WO2003048162A1 Novel crystalline compound
06/12/2003WO2003048160A1 Ring fused pyrazole derivatives
06/12/2003WO2003048156A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine
06/12/2003WO2003048153A1 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
06/12/2003WO2003048148A2 Statin-like compounds
06/12/2003WO2003048123A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/12/2003WO2003048120A2 2-aryl pyrrologpyrimidines for a1 and a3 receptors
06/12/2003WO2003047618A2 Immunotherapeutic methods and systems
06/12/2003WO2003047597A1 Combination of crystalline form of a ribofuranosyluronamide derivative and tiotropium salt
06/12/2003WO2003047578A1 Combination of a selective pde4 inhibitor and an adrenergic beta-2 receptor agonist
06/12/2003WO2003047524A2 Methods and compositions for modulating the immune system and uses thereof
06/12/2003WO2003047519A2 'compressed annular tablet with molded triturate tablet for oral and intraoral'
06/12/2003WO2003027282A9 Adamts-15, -16, -17, -18 and -19
06/12/2003WO2002103031A3 Methods for detecting and treating the early onset of aging-related conditions
06/12/2003WO2002012345A3 Soluble zcytor 11 cytokine receptors
06/12/2003WO2001085096A9 Mast cell regulation
06/12/2003US20030109813 Energy-activated targeted cancer therapy
06/12/2003US20030109671 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
06/12/2003US20030109578 Treating acute and chronical inflammatory processes in a patent in need thereof which comprises administering to such patent an amount effective therefor of a compound or salt thereof according to claim 1.
06/12/2003US20030109570 Activate a peroxisome proliferator-activated receptor (PPAR) alpha or gamma which is an intranuclear transcription factor. The compound may be used as an active ingredient to give a drug for preventing or treating a variety of diseases
06/12/2003US20030109564 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
06/12/2003US20030109540 Pharmaceutical dosage forms comprising descarboethoxyloratadine
06/12/2003US20030109535 GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure:prodrugs, stereoisomers and drugs
06/12/2003US20030109527 Novel hydroxy diphenylurea sulfonamides, compositions and intermediates thereof. The hydroxy
06/12/2003US20030109518 Substituted 1,4-benzodiazepines and uses thereof
06/12/2003US20030109511 Novel anti-inflammatory androstane derivative compositions
06/12/2003US20030109497 Novel imidazolidine derivatives, their preparation and their use
06/12/2003US20030109491 Use of heparinoid derivatives for the treatment and diagnosis of disorders which can be treated with heparinoids
06/12/2003US20030109490 Composite stimulating iNOS enzyme which induce immuno-reactant nitric oxide synthesis and process for preparing the same
06/12/2003US20030109437 Peptides and methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using proteins (and peptides derived from the amino acid sequences of such
06/12/2003US20030109429 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
06/12/2003US20030109416 methods of preventing and treating diseases wherein the involvement of apoptosis has been indicated.
06/12/2003US20030109042 Stimulant immunology system; cell differentiation; culture product; three-dimensional support
06/12/2003US20030108617 Use of a formulation made of or containing at least one dissimilated milk serum
06/12/2003US20030108588 Reduce restenosis coating on medical device
06/12/2003US20030108565 Sustained releas of protein using polymer and hydrophobic ion binding; inducing immunology response; autoimmune disease, anticancer agent
06/12/2003US20030108558 Anticholesterol agents; rheumatic diseases; mutiple sclerosis; antidiabetic agents; administering protein extracted from animal liver
06/12/2003US20030108554 GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
06/12/2003US20030108527 Maturation-promoting agent for immature dendrtic cells
06/12/2003US20030108518 TRX1 antibody and uses therefor
06/12/2003US20030108517 Membrane-bound cytokine compositions and methods of modulating an immune response using same
06/12/2003US20030108496 Compositions comprising phenyl-glycine derivatives
06/12/2003US20030107149 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
06/12/2003CA2469671A1 A process for the preparation of a non-toxic anthrax vaccine
06/12/2003CA2469151A1 Immunocytokines with modulated selectivity
06/12/2003CA2469078A1 Immunotherapeutic methods and systems
06/12/2003CA2468927A1 Ring fused pyrazole derivatives
06/12/2003CA2468907A1 Effectors of innate immunity
06/12/2003CA2468851A1 Gips, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
06/12/2003CA2468698A1 Methods and compositions for modulating the immune system and uses thereof
06/12/2003CA2468676A1 Combination of a selective pde4 inhibitor and an adrenergic beta-2 receptor agonist
06/12/2003CA2468558A1 "compressed annular tablet with molded triturate tablet for oral and intraoral"
06/12/2003CA2468525A1 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers of 4-[4-[(1r)-[4-(trifluoromethyl)phenyl]-2-methoxyethyl]-(3s)-methyl-1-piperazinyl]-4-methyl-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]
06/12/2003CA2467597A1 Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection
06/12/2003CA2467435A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/11/2003EP1318407A1 Use of aldose-1-epimerase (mutarotase) for the diagnosis and therapy of infections and sepsis
06/11/2003EP1318406A1 Use of Glycine-N-Acyl-Transferase (GNAT) for diagnosis and therapy of inflammatory diseases and sepsis
06/11/2003EP1318150A1 Novel crystals of 1,3,4-oxadiazole derivative, process for producing the crystals and medicines containing the same as the active ingredient
06/11/2003EP1318149A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing them
06/11/2003EP1317930A1 Antithrombin for prevention and therapy of vascular proliferative diseases
06/11/2003EP1317537A2 G-csf analog compositions and methods
06/11/2003EP1317536A2 Tnf receptor-like molecules and uses thereof
06/11/2003EP1317488A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine)
06/11/2003EP1317486A1 Interferon-alpha induced gene
06/11/2003EP1317476A2 Reagents for cell selection and methods of use
06/11/2003EP1317465A1 Purine derivatives
1 ... 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 ... 1172